This Series paper explores the current digital health technologies (DHT) landscape to support optimised antimicrobial use in humans and address antimicrobial resistance (AMR).
To optimise antimicrobial use, we need to be able to quantify and respond to variations occurring between host, pathogen, and antibiotic. DHT can provide additional data from a number of sources, like wearable technology, electronic health record, and artificial intelligence, that might help to deliver optimal treatment, prevent side-effects and toxicity, and minimise the impact of prescribing antimicrobials on AMR.
This paper also highlights the need to take a global and One Health approach to AMR, to clearly define data requirements for and from DHTs, and to harness the opportunities offered by digital health advances and build global technical capacity in the application of these technologies.
【MORE】